Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A pilot study

Hormone Research in Paediatrics

Volumn 74, Issue 5, 2010, Pages 328-332

  Mooij, Christiaan F ^a   Kapusta, Livia ^a   Otten, Barto J ^a   Claahsen Van Der Grinten, Hedi L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Congenital adrenal hyperplasia; Hypertension; Neonates

Indexed keywords

ANDROSTENEDIONE; FLUDROCORTISONE; HYDROCORTISONE; HYDROXYPROGESTERONE; RENIN; STEROID 21 MONOOXYGENASE;

ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; DNA DETERMINATION; FEMALE; GENOTYPE; HUMAN; MALE; NEWBORN; PILOT STUDY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEROID 21 MONOOXYGENASE DEFICIENCY; SYSTOLIC BLOOD PRESSURE;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; ALLELES; ANDROSTENEDIONE; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FLUDROCORTISONE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PILOT PROJECTS; RENIN; RETROSPECTIVE STUDIES; STEROID 21-HYDROXYLASE;

EID: 78149327899     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000308891     Document Type: Article

References (14)

1. Speiser PW, White PC: Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-788.
2. White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291.
3. Charmandari E, Chrousos GP: Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Ann NY Acad Sci 2006;1083:37-53.
4. De Silva KS, Kanumakala S, Brown JJ, Jones CL, Warne GL: 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia - a preliminary report. J Pediatr Endocrinol Metab 2004;17:1089-1095.
5. Roche EF, Charmandari E, Dattani MT, Hindmarsh PC: Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydrocylase deficiency): a preliminary report. Clin Endocrinol 2003;58:589-596.
6. Völkl T M K, Simm D, Dötsch J, Rascher W, Dörr HG: Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006;91:4888-4895.
7. Hoepffner W, Herrmann A, Willgerodt H, Keller E: Blood pressure in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 2006;19:705-711.
8. Nebesio TD, Eugster EA: Observation of hypertension in children with 21-hydroxylase deficiency: a preliminary report. Endocrine 2006;30:279-282.
9. Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y: Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene an a genuine gene. Proc Natl Acad Sci USA 1986;83:2841-2845.
10. Report of the Second Task Force on Blood Pressure Control in Children - 1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Paediatrics 1987;79:1-25.
11. Flynn JT: Neonatal hypertension: diagnosis and management. Pediatr Nephrol 2000;14:332-341.
12. Fuller PJ, Young MJ: Mechanisms of mineralocorticoid action. Hypertension 2005;46:1227-1235.
13. Frey FJ, Odermatt A, Frey BM: Glucocorticoid-mediated mineralocorticoid activation and hypertension. Curr Opini Nephrol Hypertens 2004;13:451-458.
14. Hammer F, Stewart PM: Cortisol metabolism in hypertension. Best Pract Res Clin Endocrinol Metab 2006;20:337-353.